It was 'imminent' five weeks ago according to Paul Rennie. One wonders what difficulties PAR has created for the FDA.
- Forums
- ASX - By Stock
- PAR
- FDA delay for ph 3 trial approval
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.45%
!
42.0¢

FDA delay for ph 3 trial approval, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
42.0¢ |
Change
-0.015(3.45%) |
Mkt cap ! $166.9M |
Open | High | Low | Value | Volume |
43.5¢ | 43.5¢ | 40.5¢ | $448.5K | 1.067M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1788 | 42.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.5¢ | 22499 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 157990 | 0.410 |
4 | 19219 | 0.405 |
8 | 51385 | 0.400 |
4 | 157260 | 0.395 |
6 | 39350 | 0.390 |
Price($) | Vol. | No. |
---|---|---|
0.420 | 15163 | 1 |
0.425 | 22499 | 2 |
0.430 | 18135 | 2 |
0.435 | 40254 | 7 |
0.440 | 50010 | 2 |
Last trade - 15.11pm 10/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |